Equillium to Host Business Update Call on October 1, 2019

LA JOLLA, Calif., Sept. 17, 2019 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company, leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders will be hosting a call with shareholders and the investment community to provide a business update on Tuesday, October 1, 2019.? Dan Bradbury, Equillium?s chairman and chief executive officer, and other members of Equillium?s management team will participate in the call. During the call the Company plans to provide an update on its clinical development programs and corporate milestones.